-
Latest News
- Towards a biomarker: Rethinking ME/CFS diagnostic reference intervals via machine learning, & the utility of activin B for defining symptom severity
- ME/CFS: From pathophysiological insights to novel therapeutic opportunities
- Unexplained exertional intolerance associated with impaired systemic oxygen extraction
- ME support group meets Montgomery 18 Sep 2019
- Survey of the experiences of children & young people with ME for NICE
Archives
Tag Archives: Jacqueline M Cliff
Cellular immune function in ME/CFS: increased MAIT cell frequency
Cellular immune function in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), by Jacqueline M Cliff, Elizabeth C King, Ji-Sook Lee, Nuno Sepulveda, Asia-Sofia Wolf, Caroline Kingdon, Erinna Bowman, Hazel M. Dockrell, Luis C. Nacul, Eliana Lacerda, Eleanor Riley in Front. Immunol., 16 April … Continue reading
Posted in News
Tagged Asia-Sofia Wolf, Caroline Kingdon, CD8+ T cells, Dr Luis Nacul, Elizabeth C King, Erinna Bowman, Hazel M Dockrell, immune activation, Jacqueline M Cliff, Ji-Sook Lee, MAIT cells, mucosal associated invariant cells, Natural Killer cells, NK cells, Nuno Sepulveda, T cell activation
Comments Off on Cellular immune function in ME/CFS: increased MAIT cell frequency
Hope, disappointment and perseverance: reflections of people with ME/CFS & MS participating in biomedical research
Hope, disappointment and perseverance: Reflections of people with Myalgic encephalomyelitis/ Chronic Fatigue Syndrome (ME/CFS) and Multiple Sclerosis participating in biomedical research. A qualitative focus group study, by Eliana M. Lacerda, Clare McDermott, Caroline C. Kingdon, Jack Butterworth, Jacqueline M Cliff, … Continue reading
Posted in News
Tagged biomedical research, Caroline C Kingdon, Clare McDermott, Clinical Understanding and Research Excellence in ME/CFS group, CureME, Dr Luis Nacul, Eliana M Lacerda, Jack D Butterworth, Jacqueline M Cliff, MS, Multiple Sclerosis, patient involvement
Comments Off on Hope, disappointment and perseverance: reflections of people with ME/CFS & MS participating in biomedical research
